The effect of continuous light exposure of rats on cardiac response to ischemia-reperfusion and NO-synthase activity

Physiological Research

Volumn 56, Issue SUPPL. 2, 2007, Pages

  Vazan R ^a,b   Janega, P ^a,b   Hojna S ^c   Zicha, J ^c   Simko F ^a   Pechanova O ^b,c   Styk, J ^b   Paulis, L' ^a,b,c  

^a Faculty of Medicine of Comenius University and University Hospital Bratislava   (Slovakia)

^b INSTITUTE OF CHEMISTRY   (Slovakia)

^c INSTITUTE OF PHYSIOLOGY   (Czech Republic)

Author keywords

Free radicals; Heart; Melatonin; Nitric oxide synthase; Reperfusion injury

Indexed keywords

NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ANIMAL; ARTICLE; BODY WEIGHT; CORONARY ARTERY BLOOD FLOW; DOWN REGULATION; ENZYMOLOGY; HEART ARRHYTHMIA; HEART CONTRACTION; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE CELL; HEART VENTRICLE PRESSURE; LIGHT; MALE; METABOLISM; ORGAN SIZE; OXIDATIVE STRESS; PATHOLOGY; PATHOPHYSIOLOGY; PERIODICITY; RADIATION EXPOSURE; RAT; REPERFUSION INJURY; TIME; WISTAR RAT;

ANIMALS; ARRHYTHMIAS, CARDIAC; BODY WEIGHT; CORONARY CIRCULATION; DOWN-REGULATION; LIGHT; MALE; MYOCARDIAL CONTRACTION; MYOCYTES, CARDIAC; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; ORGAN SIZE; OXIDATIVE STRESS; PERIODICITY; RATS; RATS, WISTAR; REPERFUSION INJURY; TIME FACTORS; VENTRICULAR FUNCTION, LEFT; VENTRICULAR PRESSURE;

EID: 38549145022     PISSN: 08628408     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. ALLEGRA M, REITER RJ, TAN DX, GENTILE C, TESORIERE L, LIVREA MA: The chemistry of melatonin's interaction with reactive species. J Pineal Res 34: 1-10, 2003.
2. BERNÁTOVÁ I, PECHÁŇOVÁ O, ŠIMKO F: Effect of captopril in L-NAME-induced hypertension on the rat myocardium, aorta, brain and kidney. Exp Physiol 84: 1095-1105, 1999.
3. BREDT DS, SNYDER SH: Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme. Proc Natl Acad Sci USA 87: 682-685, 1990.
4. BRIAUD SA, ZHANG BL, SANNAJUST F: Continuous light exposure and sympathectomy suppress circadian rhythm of blood pressure in rats. J Cardiovasc Pharmacol Ther 9: 97-105, 2004.
5. BROWN GM, BAR-OR A, GROSSI D, KASHUR S, JOHANSON E, YIE SM: Urinary 6-sulphatoxylmelatonin, an index of pineal function in the rat. J Pineal Res 10: 141-147, 1991.
6. CUNNANE SC, MANKU MS, OKA M, HORROBIN DF: Enhanced vascular reactivity to various vasoconstrictor agents following pinealectomy in the rat: role of melatonin. Can J Physiol Pharmacol 58: 287-293, 1980.
7. DELIBAS N, TUZMEN N, YONDEN Z, ALTUNTAS I: Effect of functional pinealectomy on hippocampal lipid peroxidation, antioxidant enzymes and N-methyl-D-aspartate receptor subunits 2A and 2B in young and old rats. Neuro Endocrinol Lett 23: 345-350, 2002.
8. DEPRE C, FIERAIN L, HUE L: Activation of nitric oxide synthase by ischaemia in the perfused heart. Cardiovasc Res 33: 82-87, 1997.
9. GIROUARD H, DENAULT C, CHULAK C, DE CHAMPLAIN J: Treatment by n-acetylcysteine and melatonin increases cardiac baroreflex and improves antioxidant reserve. Am J Hypertens 17: 947-954, 2004.
10. HOLMES SW, SUGDEN D: The effect of melatonin on pinealectomy-induced hypertension in the rat. Br J Pharmacol 56: 360-361, 1976.
11. KAWAHARA K, TAKASE M, YAMAUCHI Y: Increased vulnerability to ischemia/reperfusion-induced ventricular tachyarrhythmias by pre-ischemic inhibition of nitric oxide synthase in isolated rat hearts. Cardiovasc Pathol 12: 49-56, 2003.
12. KOGURE K, WATSON R, BUSTO R, ABE K: Potentiation of lipid peroxides by ischemia in rat brain. Neurochem Res 7: 437-453, 1982.
13. LEAF A, KANG JX: Prevention of cardiac sudden death by N-3 fatty acids: a review of the evidence. J Intern Med 240: 5-12, 1996.
14. MAXWELL AJ: Mechanisms of dysfunction of the nitric oxide pathway in vascular diseases. Nitric Oxide 6: 101-124, 2002.
15. MEI YA, LEE PP, WEI H, ZHANG ZH, PANG SF: Melatonin and its analogs potentiate the nifedipine-sensitive high-voltage-activated calcium current in the chick embryonic heart cells. J Pineal Res 30: 13-21, 2001.
16. MIZRAK B, PARLAKPINAR H, ACET A, TURKOZ Y: Effects of pinealectomy and exogenous melatonin on rat hearts. Acta Histochem 106: 29-36, 2004.
17. G-nitro-L-arginine improves myocardial function following ischemia/reperfusion in isolated perfused rat heart. J Mol Cell Cardiol 27: 419-426, 1995.
18. PABLA R, CURTIS MJ: Effects of NO modulation on cardiac arrhythmias in the rat isolated heart. Circ Res 77: 984-992, 1995.
19. PAULIS ?, JANEGA P, PECHÁŇOVÁ O, ZICHA J, HOJNÁ S, VAŽAN R: Continuous light exposure protects rat heart against ischemia-reperfusion injury. Physiol Res 55: 2P, 2006.
20. REBUFFAT P, MAZZOCCHI G, GOTTARDO G, COI A, MENEGHELLI V, NUSSDORFER GG: An ultrastructural morphometric study of the effects of chronic melatonin administration on the zona fasciculata of rat adrenal cortex. J Submicrosc Cytol 19: 415-421, 1987.
21. REITER RJ: Melatonin: Lowering the high price of free radicals. News Physiol Sci 15: 246-250, 2000.
22. SAHNA E, OLMEZ E, ACET A: Effects of physiological and pharmacological concentrations of melatonin on ischemia-reperfusion arrhythmias in rats: can the incidence of sudden cardiac death be reduced? J Pineal Res 32: 194-198, 2002.
23. SAHNA E, PARLAKPINAR H, TURKOZ Y, ACET A: Protective effects of melatonin on myocardial ischemia/reperfusion induced infarct size and oxidative changes. Physiol Res 54: 491-495, 2005.
24. ŠIMKO F, PAULIS, ?: Melatonin as a potential antihypertensive treatment. J Pineal Res 42: 319-322, 2007.
25. TAN DX, MANCHESTER LC, REITER RJ, QI WB, KARBOWNIK M, CALVO JR: Significance of melatonin in antioxidative defense system: reactions and products. Biol Signals Recept 9: 137-159, 2000.
26. VAŽAN R, STYK J, BÉDER I, PANCZA D: Effect of melatonin on the isolated heart in the standard perfusion conditions and in the conditions of calcium paradox. Gen Physiol Biophys 22: 41-50, 2003.
27. WALKER MJ, CURTIS MJ, HEARSE DJ, CAMPBELL RW, JANSE MJ, YELLON DM, COBBE SM, COKER SJ, HARNESS JB, HARRON DW: The Lambeth Conventions: guidelines for the study of arrhythmias in ischaemia infarction, and reperfusion. Cardiovasc Res 22: 447-455, 1988.
28. WALLERATH T, WITTE K, SCHAFER SC, SCHWARZ PM, PRELLWITZ W, WOHLFART P, KLEINERT H, LEHR HA, LEMMER B, FORSTERMANN U: Down-regulation of the expression of endothelial NO synthase is likely to contribute to glucocorticoid-mediated hypertension. Proc Natl Acad Sci USA 96: 13357-13362, 1999.
29. WOOLFSON RG, PATEL VC, NEILD GH, YELLON DM: Inhibition of nitric oxide synthesis reduces infarct size by an adenosine-dependent mechanism. Circulation 91: 1545-1551, 1995.
30. ZANOBONI A, ZANOBONI-MUCIACCIA W: Experimental hypertension in pinealectomized rats. Life Sci 6: 2327-2331, 1967.